ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Geron Corp Del Dl 001

Geron Corp Del Dl 001 (0IV3)

3.63
0.00
(0.00%)
終了 6月19日 12:30AM

Geron Corp Del Dl 001 (0IV3) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
3.63
( - )
買値
3.63
売値
3.63
出来高
14,502
0.00 日の範囲 0.00
3.63 52 週間の範囲 3.63
時価総額
前日終値
3.63
始値
-
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 16,194,817
発行済株式数
641,520,974
配当利回り
PER
-11.7
1 株当たり利益 (EPS)
-0.1
歳入
196.12M
純利益
-67.31M

Geron Corp Del Dl 001 について

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company’s product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes wit... Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company’s product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
Foster City, United States
設立
1990
Geron Corp Del Dl 001 is listed in the sector of the ロンドン証券取引所 with ticker 0IV3. The last closing price for Geron Corp Del Dl 001 was US$3.63. Over the last year, Geron Corp Del Dl 001 shares have traded in a share price range of US$ 3.63 to US$ 3.63.

Geron Corp Del Dl 001 currently has 641,520,974 shares in issue. The market capitalisation of Geron Corp Del Dl 001 is US$2.33 billion. Geron Corp Del Dl 001 has a price to earnings ratio (PE ratio) of -11.70.

0IV3 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
26003.633.633.63334283.63DE
52003.633.633.63352533.63DE
156003.633.633.63179033.63DE
260003.633.633.63119513.63DE

0IV3 - Frequently Asked Questions (FAQ)

What is the current Geron Corp Del Dl 001 share price?
The current share price of Geron Corp Del Dl 001 is US$ 3.63
How many Geron Corp Del Dl 001 shares are in issue?
Geron Corp Del Dl 001 has 641,520,974 shares in issue
What is the market cap of Geron Corp Del Dl 001?
The market capitalisation of Geron Corp Del Dl 001 is USD 2.33B
What is the 1 year trading range for Geron Corp Del Dl 001 share price?
Geron Corp Del Dl 001 has traded in the range of US$ 3.63 to US$ 3.63 during the past year
What is the PE ratio of Geron Corp Del Dl 001?
The price to earnings ratio of Geron Corp Del Dl 001 is -11.7
What is the cash to sales ratio of Geron Corp Del Dl 001?
The cash to sales ratio of Geron Corp Del Dl 001 is 3.86
What is the registered address of Geron Corp Del Dl 001?
The registered address for Geron Corp Del Dl 001 is 919 East Hillsdale Boulevard, Foster City, California, 94404
What is the Geron Corp Del Dl 001 website address?
The website address for Geron Corp Del Dl 001 is www.geron.com

0IV3 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード